NBIX NEUROCRINE BIOSCIENCES INC

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed Jun 2, 2026 Processed 10d 10h ago
Insider cluster: 3 insiders, $2.7M total
Latest settled — T+1d ⚠ clustered
NBIX ▲ +1.58% at T+1d
NEUTRAL call ✓ call won +1.58% · α vs SPY +1.18% · entry $164.23 → $166.83
Next anchor: T+5d due 4d ago
Currently $159.76 · -2.72% from $164.23 entry
Entry anchored
Jun 2, 2026
via day open
T+1d
+1.58%
call +1.58% · α +1.18%
$166.83
settled 10d ago
T+5d
call — · α —
due 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Three Neurocrine executives (CSO, Chief Corp. Affairs Officer, Chief Regulatory Officer) sold a total of $2.73M in open-market shares over a 5-day window. The sales are tied to option exercises and are small relative to the $16.2B market cap (~0.017%), making them routine portfolio diversification rather than a bearish signal. Director grants on May 27 are non-cash and carry no economic signal.

Key Financial Metrics

Direction
selling
Total Value
$2.7M
Insiders
3

Actionable Insight

Insider sales are routine and immaterial relative to market cap. No bearish signal. Monitor next earnings (likely late July) for any guidance changes, but this cluster does not indicate informed selling.

Key Facts

  • Total open-market sales: $2.73M across 3 insiders (CSO, Chief Corp. Affairs Officer, Chief Regulatory Officer)
  • Sales represent ~0.017% of NBIX's $16.2B market cap — well below the 0.1% materiality threshold
  • CSO Onyia Jude sold 22,000 shares for $3.47M total across two days, all tied to option exercises at $84.74/share
  • Chief Regulatory Officer Delaet Ingrid sold 2,261 shares for $354K, also tied to option exercises
  • Seven directors received non-cash stock grants on May 27 — no economic signal
  • No 10b5-1 plan disclosure in the filing, but the pattern (option exercise + immediate sale) is standard for tax coverage

Financial Impact

Total insider sales of $2.73M, or 0.017% of market cap — immaterial

insider_sales

Risk Factors

  • No material risk identified from this insider activity alone

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (36 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1780438125207
14 reports for NBIX
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +1.74%Apr 6, 2026
Filters
Rows
Reports for NBIX — sortable, filterable
Type Now
Jun 9, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
$165.21 awaiting T+1awaiting T+1$159.76 (−3.30%)
Jun 8, 2026
4d ago
Insider Cluster
NEUTRAL ★ 2/10
$163.08 awaiting T+1awaiting T+1$159.76 (−2.04%)
Jun 8, 2026
4d ago
Insider Cluster
NEUTRAL ★ 4/10
$163.08 awaiting T+1awaiting T+1$159.76 (−2.04%)
Jun 4, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
$167.53 awaiting T+1awaiting T+1$159.76 (−4.64%)
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 2/10
$164.23 $166.83▲ +1.58%▲ +1.18%$159.76 (−2.72%)
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 3/10
$164.23 $166.83▲ +1.58%▲ +1.18%$159.76 (−2.72%)
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 2/10
$164.23 $166.83▲ +1.58%▲ +1.18%$159.76 (−2.72%)
May 29, 2026
14d ago
Insider Cluster
NEUTRAL ★ 3/10
$160.48 $154.78▼ −3.55%▼ −3.70%$159.76 (−0.45%)
May 28, 2026
15d ago
Insider Cluster
NEUTRAL ★ 4/10
$157.77 $160.48▲ +1.72%▲ +1.46%$159.76 (+1.26%)
May 21, 2026
22d ago
Insider Cluster
NEUTRAL ★ 4/10
$156.50 $155.72▼ −0.50%▼ −1.08%$159.76 (+2.09%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (53h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access